Hypophysectomy for prolactinomas following dopamine agonist therapy

Comment

J A Thomson. Clin Endocrinol (Oxf). 1996 Nov.

. 1996 Nov;45(5):649.

No abstract available

Comment on

The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.
Soule SG, Farhi J, Conway GS, Jacobs HS, Powell M. Soule SG, et al. Clin Endocrinol (Oxf). 1996 Jun;44(6):711-6. doi: 10.1046/j.1365-2265.1996.738559.x. Clin Endocrinol (Oxf). 1996. PMID: 8759184

[Clinical aspects, morphology and biology of prolactinomas after therapy with dopamine agonists. A review of the literature].
Kobras G. Kobras G. Pathologe. 1992 Jul;13(4):183-9. Pathologe. 1992. PMID: 1508856 Review. German. No abstract available.
[Gamma knife treatment for pituitary prolactinomas].
Ma ZM, Qiu B, Hou YH, Liu YS. Ma ZM, et al. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Oct;31(5):714-6. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 17062937 Chinese.
Transsphenoidal hypophysectomy: a critical review.
Siegel MB, Hendrix RA. Siegel MB, et al. Trans Pa Acad Ophthalmol Otolaryngol. 1990;42:1002-7. Trans Pa Acad Ophthalmol Otolaryngol. 1990. PMID: 2084974 Review.
Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
Delgrange E, Sassolas G, Perrin G, Jan M, Trouillas J. Delgrange E, et al. Acta Neurochir (Wien). 2005 Jul;147(7):751-7; discussion 757-8. doi: 10.1007/s00701-005-0498-2. Epub 2005 Mar 14. Acta Neurochir (Wien). 2005. PMID: 15971099
Microprolactinomas in males treated by transsphenoidal surgery.
Wolfsberger S, Czech T, Vierhapper H, Benavente R, Knosp E. Wolfsberger S, et al. Acta Neurochir (Wien). 2003 Nov;145(11):935-40; discussion 940-1. doi: 10.1007/s00701-003-0134-y. Acta Neurochir (Wien). 2003. PMID: 14628197 Clinical Trial.